Last data update: Dec 02, 2024. (Total: 48272 publications since 2009)
Records 1-4 (of 4 Records) |
Query Trace: Pierre JS[original query] |
---|
Increase in reported cholera cases in Haiti following Hurricane Matthew: An interrupted time series model
Hulland E , Subaiya S , Pierre K , Barthelemy N , Pierre JS , Dismer A , Juin S , Fitter D , Brunkard J . Am J Trop Med Hyg 2019 100 (2) 368-373 Matthew, a category 4 hurricane, struck Haiti on October 4, 2016, causing widespread flooding and damage to buildings and crops, and resulted in many deaths. The damage caused by Matthew raised concerns of increased cholera transmission particularly in Sud and Grand'Anse departments, regions which were hit most heavily by the storm. To evaluate the change in reported cholera cases following Hurricane Matthew on reported cholera cases, we used interrupted time series regression models of daily reported cholera cases, controlling for the impact of both rainfall, following a 4-week lag, and seasonality, from 2013 through 2016. Our results indicate a significant increase in reported cholera cases after Matthew, suggesting that the storm resulted in an immediate surge in suspect cases, and a decline in reported cholera cases in the 46-day post-storm period, after controlling for rainfall and seasonality. Regression models stratified by the department indicate that the impact of the hurricane was regional, with larger surges in the two most highly storm-affected departments: Sud and Grand'Anse. These models were able to provide input to the Ministry of Health in Haiti on the national and regional impact of Hurricane Matthew and, with further development, could provide the flexibility of use in other emergency situations. This article highlights the need for continued cholera prevention and control efforts, particularly in the wake of natural disasters such as hurricanes, and the continued need for intensive cholera surveillance nationally. |
Strengthening national disease surveillance and response-Haiti, 2010-2015
Juin S , Schaad N , Lafontant D , Joseph GA , Barzilay E , Boncy J , Barrais R , Louis FJ , Jean Charles NL , Corvil S , Barthelemy N , Dismer A , Pierre JS , Archer RW , Antoine M , Marston B , Katz M , Dely P , Adrien P , Fitter DL , Lowrance D , Patel R . Am J Trop Med Hyg 2017 97 12-20 Haiti's health system has faced many challenges over the years, with competing health priorities in the context of chronic financial and human resource limitations. As a result, the existing notifiable disease surveillance system was unable to provide the most basic epidemiologic data for public health decision-making and action. In the wake of the January 2010 earthquake, the Haitian Ministry of Public Health and Population collaborated with the U.S. Centers for Disease Control and Prevention, the Pan American Health Organization, and other local and international partners to implement a functional national surveillance system. More than 7 years later, it is important to take the opportunity to reflect on progress made on surveillance and response in Haiti, including disease detection, reporting, outbreak investigation, and response. The national epidemiologic surveillance network that started with 51 sites in 2010 has been expanded to 357 sites as of December 2015. Disease outbreaks identified via the surveillance system, or other surveillance approaches, are investigated by epidemiologists trained by the Ministry of Health's Field Epidemiology Training Program. Other related surveillance modules have been developed on the same model and electronic platform, allowing the country to document the impact of interventions, track progress, and monitor health problems. Sustainability remains the greatest challenge since most of the funding for surveillance come from external sources. |
Transmission of Zika Virus - Haiti, October 12, 2015-September 10, 2016
Journel I , Andrecy LL , Metellus D , Pierre JS , Faublas RM , Juin S , Dismer AM , Fitter DL , Neptune D , Laraque MJ , Corvil S , Pierre M , Buteau J , Lafontant D , Patel R , Lemoine JF , Lowrance DW , Charles M , Boncy J , Adrien P . MMWR Morb Mortal Wkly Rep 2017 66 (6) 172-176 Zika virus disease is caused by infection with a flavivirus with broad geographic distribution and is most frequently transmitted by the bite of an infected mosquito. The disease was first identified in the World Health Organization's Region of the Americas in 2015 and was followed by a surge in reported cases of congenital microcephaly in Brazil; Zika virus disease rapidly spread to the rest of the region and the Caribbean, including Haiti. Infection with the virus is associated with adverse fetal outcomes and rare neurologic complications in adults. The magnitude of public health issues associated with Zika virus led the World Health Organization to declare the Zika virus outbreak a Public Health Emergency of International Concern on February 1, 2016 (2). Because many persons with mild Zika virus disease are asymptomatic and might not seek care, it is difficult to estimate the actual incidence of Zika virus infection. During October 12, 2015-September 10, 2016, the Haitian Ministry of Public Health and Population (Ministere de la Sante Publique et de la Population [MSPP]) detected 3,036 suspected cases of Zika virus infection in the general population, 22 suspected cases of Zika virus disease among pregnant women, 13 suspected cases of Guillain-Barre syndrome (GBS), and 29 suspected cases of Zika-associated congenital microcephaly. Nineteen (0.6%) patients with suspected Zika virus disease, residing in Ouest (10 patients), Artibonite (six), and Centre (three) administrative departments, have been confirmed by laboratory testing, including two among pregnant women and 17 in the general population. Ongoing laboratory-enhanced surveillance to monitor Zika virus disease in Haiti is important to understanding the outbreak and ensuring effective response activities. |
CDC’s early response to a novel viral disease, Middle East respiratory syndrome coronavirus (MERS-CoV), September 2012-May 2014
Williams HA , Dunville RL , Gerber SI , Erdman DD , Pesik N , Kuhar D , Mason KA , Haynes L , Rotz L , Pierre JS , Poser S , Bunga S , Pallansch MA , Swerdlow DL . Public Health Rep 2015 130 (4) 307-317 The first ever case of Middle East Respiratory Syndrome Coronavirus (MERSCoV) was reported in September 2012. This report describes the approaches taken by CDC, in collaboration with the World Health Organization (WHO) and other partners, to respond to this novel virus, and outlines the agency responses prior to the first case appearing in the United States in May 2014. During this time, CDC’s response integrated multiple disciplines and was divided into three distinct phases: before, during, and after the initial activation of its Emergency Operations Center. CDC’s response to MERS-CoV required a large effort, deploying at least 353 staff members who worked in the areas of surveillance, laboratory capacity, infection control guidance, and travelers’ health. This response built on CDC’s experience with previous outbreaks of other pathogens and provided useful lessons for future emerging threats. |
- Page last reviewed:Feb 1, 2024
- Page last updated:Dec 02, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure